Cover Image

Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice

Recent findings in molecular biology implicate the involvement of proprotein convertase subtilisin/kexin type 9 (PCSK9) in low-density lipoprotein receptor (LDLR) protein regulation. The cholesterol-lowering potential of anti-PCSK9 antisense oligonucleotides (AONs) modified with bridged nucleic acid...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tsuyoshi Yamamoto (Author), Mariko Harada-Shiba (Author), Moeka Nakatani (Author), Shunsuke Wada (Author), Hidenori Yasuhara (Author), Keisuke Narukawa (Author), Kiyomi Sasaki (Author), Masa-Aki Shibata (Author), Hidetaka Torigoe (Author), Tetsuji Yamaoka (Author), Takeshi Imanishi (Author), Satoshi Obika (Author)
Format:	Book
Published:	Elsevier, 2012-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development of a 2',4'-BNA/LNA-based siRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In Vivo
by: Shunsuke Wada, et al.
Published: (2012)

Favorable efficacy and reduced acute neurotoxicity by antisense oligonucleotides with 2',4' -BNA/LNA with 9-(aminoethoxy)phenoxazine
by: Taiki Matsubayashi, et al.
Published: (2024)

Favorable efficacy and reduced acute neurotoxicity by antisense oligonucleotides with 2',4'-BNA/LNA with 9-(aminoethoxy)phenoxazine
by: Taiki Matsubayashi, et al.
Published: (2024)

Effect of Artemisia aucheri Extract on Atherogenic Lipids and Atherogenesis in Hypercholesterolemic Rabbits
by: N Jafari Dinani, et al.
Published: (2007)

Anti-atherogenic Effects of a New Thienylacylhydrazone Derivative, LASSBio-788, in Rats Fed a Hypercholesterolemic Diet
by: Nadia Alice Vieira da Motta, et al.
Published: (2013)

Effects of Methanol Extract of Breadfruit (Artocarpus altilis) on Atherogenic Indices and Redox Status of Cellular System of Hypercholesterolemic Male Rats
by: Oluwatosin Adekunle Adaramoye, et al.
Published: (2014)

Increased Circulating Levels of PCSK9 and Pro-Atherogenic Lipoprotein Profile in Pregnant Women with Maternal Supraphysiological Hypercholesterolemia
by: Claudette Cantin, et al.
Published: (2022)

Treatment with PCSK9 Inhibitor Evolocumab Improves Vascular Oxidative Stress and Arterial Stiffness in Hypercholesterolemic Patients with High Cardiovascular Risk
by: Alessia Silla, et al.
Published: (2023)

Population PK/PD modeling of low‐density lipoprotein cholesterol response in hypercholesterolemic participants following administration of bococizumab, a potent anti‐PCSK9 monoclonal antibody
by: Ellen Q. Wang, et al.
Published: (2023)

Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides
by: Tsuyoshi Yamamoto, et al.
Published: (2021)

Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides
by: Fumito Wada, et al.
Published: (2021)

Base-modified aptamers obtained by cell-internalization SELEX facilitate cellular uptake of an antisense oligonucleotide
by: Keisuke Tanaka, et al.
Published: (2021)

Comprehensive expressional analyses of antisense transcripts in colon cancer tissues using artificial antisense probes
by: Kanai Akio, et al.
Published: (2011)

Reduction of serum cholesterol in hypercholesterolemic rats by Guar gum
by: Saeed Samarghandian, et al.
Published: (2011)

Reduction of serum cholesterol in hypercholesterolemic rats by Guar gum
by: Mohammad Reza Haeri
Published: (2011)

Lycopene Modulates Oxidative Stress and Inflammation in Hypercholesterolemic Rats
by: Tarfa Albrahim
Published: (2022)

Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes
by: Kiyoko Setoguchi, et al.
Published: (2017)

Atherogenic risk factors of hypertension in an elderly
by: Jorge Armando Poll Pineda, et al.
Published: (2016)

Atherogenic Risk Factors in Medical Students
by: Airam Navarro Palacios, et al.
Published: (2020)

Atherogenic Risk Factors in Medical Students
by: Airam Navarro Palacios, et al.
Published: (2020)

Comparative modeling, structure and active site prediction of Sclerotinia disease-resistant gene BnaMPK3 in Oilseed rape (Brassica napus)
by: Zeshan Haider, et al.
Published: (2020)

Lipid-lowering property of Clausena anisum-olens in hypercholesterolemic rats
by: Anbel M. Bautista, et al.
Published: (2017)

Hypocholesterolemic efficacy of royal jelly in healthy mild hypercholesterolemic adults
by: Hui-Fang Chiu, et al.
Published: (2017)

Antisense Therapy
Published: (2019)

Atherogenic indices and smoking habits in cigarette smokers
by: Ayu Agbecha, et al.
Published: (2018)

A Comprehensive Review of PCSK9 Inhibitors
by: Caroline Coppinger BS, et al.
Published: (2022)

The Anti-Thrombotic Effects of PCSK9 Inhibitors
by: Martin Jozef Péč, et al.
Published: (2023)

Bioefficacy of red cabbage against hypercholesterolemic diet mediated oxidative stress
by: Faiza Ashfaq, et al.
Published: (2019)

Salix alba attenuated oxidative stress in the heart and kidney of hypercholesterolemic rabbits
by: Narges Amel Zabihi, et al.
Published: (2017)

TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice
by: Robert Stöhr, et al.
Published: (2015)

Antihyperlipidemic effect of Trichilia connaroides in hypercholesterolemic rats and its possible mechanism
by: Prasanna Gurunath Subbarao, et al.
Published: (2011)

VLDL receptor gene therapy for reducing atherogenic lipoproteins
by: Ronald M. Krauss, et al.
Published: (2023)

Amido-Bridged Nucleic Acid-Modified Antisense Oligonucleotides Targeting SYT13 to Treat Peritoneal Metastasis of Gastric Cancer
by: Mitsuro Kanda, et al.
Published: (2020)

Safety and Tolerability of PCSK9 Inhibitors: Current Insights
by: Kosmas CE, et al.
Published: (2020)

Analysis of The Use of PCSK9 Inhibitors in Clinical Practice
by: S. Yu. Volkova, et al.
Published: (2023)

PCSK9 Inhibitor Therapy as an Alternative for Statin Intolerance
by: K. O. Shnaider, et al.
Published: (2023)

Therapeutic Effect of Hijamah (Cupping Therapy) on Lipid Profiles and Apolipoprotein in Hypercholesterolemic Patients
by: Ratna Pelawati, et al.
Published: (2022)

Paeoniflorin alleviates liver injury in hypercholesterolemic rats through the ROCK/AMPK pathway
by: Tong Liu, et al.
Published: (2022)

OBICETRAPIB TARGETS ALL ATHEROGENIC LIPOPROTEINS BEYOND LDL-C
by: Michael Davidson, MD
Published: (2024)

Variability of Values for the Atherogenic Index (ATH index) in Healthy Men
by: Anastasiya M Kaneva, et al.
Published: (2021)